Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability

J Neurochem. 2005 Apr;93(2):502-12. doi: 10.1111/j.1471-4159.2005.03058.x.

Abstract

Although the roles of cyclin-dependent kinase 5 (Cdk5) in neurodevelopment and neurodegeneration have been studied extensively, regulation of Cdk5 activity has remained largely unexplored. We report here that glutamate, acting via NMDA or kainate receptors, can induce a transient Ca(2+)/calmodulin-dependent activation of Cdk5 that results in enhanced autophosphorylation and proteasome-dependent degradation of a Cdk5 activator p35, and thus ultimately down-regulation of Cdk5 activity. The relevance of this regulation to synaptic plasticity was examined in hippocampal slices using theta burst stimulation. p35(-/-) mice exhibited a lower threshold for induction of long-term potentiation. Thus excitatory glutamatergic neurotransmission regulates Cdk5 activity through p35 degradation, and this pathway may contribute to plasticity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cyclin-Dependent Kinase 5
  • Cyclin-Dependent Kinases / genetics
  • Cyclin-Dependent Kinases / metabolism*
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / physiology
  • Glutamic Acid / pharmacology*
  • Mice
  • Mice, Inbred ICR
  • Phosphotransferases / genetics
  • Phosphotransferases / metabolism*
  • Receptors, Glutamate / genetics
  • Receptors, Glutamate / metabolism*

Substances

  • Cdk5r1 protein, mouse
  • Receptors, Glutamate
  • Glutamic Acid
  • Phosphotransferases
  • Cyclin-Dependent Kinase 5
  • Cdk5 protein, mouse
  • Cyclin-Dependent Kinases